| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6927
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6903
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_352310c965fa8daa80874e3f78863c4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_536e0293cecb5dcc21b9ffb0a2280bd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94ae36b29cee0da55f139a9b7b4d9c83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dedef95a9da9df24931fc71b5455121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f08f3f97bdb1c15c6f37142a742870c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8097d688710a7e71b5a46661b015460 |
| publicationDate |
2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10183079-B2 |
| titleOfInvention |
Hydrogel microspheres containing peptide ligands for growth factor regulation in blood products |
| abstract |
Vascular endothelial growth factor VEGF-sequestering hydrogel microspheres that have been prepared to selectively bind VEGF from blood products are disclosed herein. In one particular embodiment, the microspheres bind VEGF as part of an intra-operative process such that the growth factor can be removed from the blood products before the products are used in a clinical procedure. |
| priorityDate |
2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |